Cellular Casein Kinase 2 and Protein Phosphatase 2A Modulate Replication Site Assembly of Bluetongue Virus. by Mohl, Bjorn-Patrick & Roy, Polly
Mohl, BP; Roy, P (2016) Cellular casein kinase 2 and protein phos-
phatase 2A modulate replication site assembly of Bluetongue virus.
The Journal of biological chemistry, 291 (28). pp. 14566-74. ISSN
0021-9258 DOI: 10.1074/jbc.M116.714766
Downloaded from: http://researchonline.lshtm.ac.uk/2550073/
DOI: 10.1074/jbc.M116.714766
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
Cellular Casein Kinase 2 and Protein Phosphatase 2A
Modulate Replication Site Assembly of Bluetongue Virus*
Received for publication, January 8, 2016, and in revised form, May 11, 2016 Published, JBC Papers in Press,May 16, 2016, DOI 10.1074/jbc.M116.714766
Bjorn-Patrick Mohl and Polly Roy1
From the Department of PathogenMolecular Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and
Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom
A number of cytoplasmic replicating viruses produce cyto-
plasmic inclusion bodies or protein aggregates; however, a hall-
mark of viruses of the Reoviridae family is that they utilize these
sites for purposes of replication and capsid assembly, function-
ing as viral assembly factories. Here we have used bluetongue
virus (BTV) as amodel system for this broad family of important
viruses to understand the mechanisms regulating inclusion
body assembly. Newly synthesized viral proteins interact with
sequestered viral RNA molecules prior to capsid assembly and
double-stranded RNA synthesis within viral inclusion bodies
(VIBs). VIBs are predominantly comprised of a BTV-encoded
non-structural protein 2 (NS2). Previous in vitro studies indi-
cated that casein kinase 2 (CK2) mediated the phosphorylation
of NS2, which regulated the propensity of NS2 to form larger
aggregates. Using targeted pharmacological reagents, specific
mutation in the viral genome by reverse genetics and confocal
microscopy, herewe demonstrate that CK2 activity is important
for BTV replication. Furthermore, we show that a novel host cell
factor, protein phosphatase 2A, is involved in NS2 dephosphor-
ylation and that, together with CK2, it regulates VIB morphol-
ogy and virus replication. Thus, these two host enzymes influ-
ence the dynamic nature of VIB assembly/disassembly, and
these concerted activities may be relevant to the assembly and
the release of these cores from VIBs.
Reversible protein phosphorylation is the most pervasive
mechanismwithin cells to facilitate the continual adjustment of
anabolic, catabolic, and signal transduction events to maintain
cellular equilibrium (1). In eukaryotes, protein kinases catalyze
the transfer of the -phosphate from ATP predominantly to
serine, threonine, and tyrosine residues (2, 3). Conversely, pro-
tein phosphatases catalyze the removal of such negatively
charged phosphorylmoieties, orchestrating dephosphorylation
in highly regulated kinase-phosphatase dynamics and networks
(4, 5). The addition or removal of such negatively charged phos-
phorylmoieties can influence protein function through confor-
mational changes that alter the affinity for ligands, stability, or
subcellular localization (6). Certain RNA viruses, such as HIV,
type 1 (7), Ebola virus (8), vesicular stomatitis virus (9), rubella
virus (10), and hepatitis C virus (11), utilize protein phosphor-
ylation as a crucial mechanism for the regulation of viral RNA
binding activity, transcription, replication, and virus assembly.
For the members of Reoviridae, it is the virally encoded non-
structural proteins that are phosphorylated, such as rotavirus
NSP5 (12) and involved in many of these activities during the
virus life cycle.However, these donot constitute components of
the mature virus particles.
Bluetongue virus (BTV),2 the prototypemember of theOrbi-
virus genus in the Reoviridae family, is an insect-vectored
emerging pathogen of wild ruminants and livestock (with mor-
tality reaching 70% in sheep) inmany parts of the world. BTV is
an icosahedral double-capsid virus, and the virion particle is an
architecturally complex structure. It is composed of seven
structural proteins (VP1–VP7) organized in two concentric
protein shells surrounding a genome of 10 segmented double-
stranded RNAs. In addition to seven structural proteins, four
non-structural proteins (NS1–NS4) are also synthesized in the
infected host cells. Of the 11 viral proteins synthesized during
BTV infection, only the nonstructural protein 2 (NS2) is phos-
phorylated (13, 14) and is also the principal component of cyto-
plasmic viral inclusion bodies (VIBs), the site of viral assembly
(15). NS2 is phosphorylated at Ser-249 and Ser-259 (16). NS2
expressed singly or in the context of an infection amalgamates
in the cytoplasm to form globular aggregates and acts as a scaf-
fold or concentrator in the cytoplasm for viral RNAs and
proteins.
NS2 is responsible for recruiting the newly synthesized core
(inner capsid) components, including the core proteins and 10
single-stranded RNA transcripts into the VIBs, where core
assembly occurs (16, 17). Furthermore, although NS2 is not a
component of the mature virus, it is indispensable for the
assembly of the primary replicase complex to initiate secondary
replication in the infected host cells (18).
Because our previous studies suggested that cellular CK2 is
responsible for NS2 phosphorylation (16), we have undertaken
further examinations of whether CK2 activity is indeed impor-
tant for BTV replication and whether a phosphatase activity
complements the activity of the kinase (CK2), mediating NS2
phosphorylation dynamics. Accumulating data obtained froma
series of in vivo studies using various specific pharmacological
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important for BTV replication. Furthermore, we identified a
novel NS2 interaction partner, protein serine/threonine phos-
phatase type 2A (PP2A), whose activity also appeared to be
important for BTV replication.
Results
CK2 Activity Is Important for Viral Replication and for Reg-
ulating VIBMorphology during BTV Infection—The phosphor-
ylation state of two serine residues at positions 249 and 259
within NS2 regulates its capacity to amalgamate and form large
VIBs (16); however, non-phosphorylatedNS2 retains the capacity
to oligomerize and form small aggregates (16, 19, 20). Previous
studies implicated that the cellular kinaseCK2mediates thismod-
ification independent of infection (16). To obtain direct evidence
that CK2 activity is important for virus replication by regulating
NS2phosphorylation,weuseda specific inhibitor forCK2, 4,5,6,7-
tetrabromobenzotriazole (TBB) (21), an ATP/GTP-competitive
inhibitor of CK2. HeLa cells were infected with BTV1 (MOI 1)
for 4 hprior to treatmentwithTBBat a gradient of concentrations
(100–10 M) for 20 h. Subsequent Western blotting analysis
showed that TBB treatment interfered with viral replication,
decreasing both NS2 and VP3 protein levels (Fig. 1A).WhenNS2
protein levels were normalized to host cell -Actin levels via den-
sitometry in replicate experiments, TBB (100, 50, and 20 M) sig-
nificantly decreased BTV1 replication compared with the control
(Fig. 1B). 100 M TBB decreased NS2 protein levels by60% (
11%), 50Mby30% ( 5%), and 20Mby20% ( 8%).More-
over, we also observed an 2 log10 and 1 log10 decrease in
virus titer in virus derived from cells treated with 100 and 50 M
(Fig. 1C).
FIGURE 1. CK2 activity is important for viral replication and for regulating VIBmorphology during BTV infection.HeLa cells infected with BTV1 (MOI
1) were treated 4 h.p.i. with concentrations of 100, 50, 20, and 10 M TBB for 20 h. A, samples were analyzed by Western blotting using specific antibodies as
indicated. B, densitometry analysis of the Western blots expressed as a percentage. C, virus titer derived from HeLa cells infected with BTV1 (MOI  1) and
treated 4 h.p.i. with concentrations of 100, 50, 20, and 10M TBB for 20 h.D, HeLa cells infectedwith BTV1 (MOI 1) were treated 20 h.p.i. with concentrations
of 100, 50, 20, and 10 M TBB for 4 h. E, VIBs denoted by NS2 staining were quantified using Volocity software, and their size was determined in replicate
experiments ofD. Error bars represent the standard deviation (Western blots) and standard error (confocal images) values of stimulations from three indepen-
dent experiments. *, p 0.05.
CK2 and PP2A Regulate BTV Assembly Sites
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To investigate the effect on VIB morphology, cells were
treated with a gradient of TBB concentrations (100–10M) for
4 h and analyzed by immunofluorescence confocalmicroscopy.
As a result of CK2 inhibition, VIB morphology was altered and
appeared smaller than the normal VIBs. Furthermore, NS2 was
also more dispersed throughout the cytoplasm when treated
with TBB (Fig. 1D). To quantify VIB size, we calculated the
surface area of VIBs. Immunofluorescence images were col-
lated using Volocity software. The quantification data revealed
that treatment of virus-infected cells with 100 and 50 M TBB
significantly decreased mean VIB size (square micrometers) by
30% ( 6%) and20% ( 4%), respectively (Fig. 1E).
To support the data obtained from CK2 inhibition, we sub-
sequently undertook siRNA knockdown experiments targeting
CK2a that contains the catalytic subunit of the kinase tetramer.
HeLa cells were mock-transfected or transfected with either a
control siRNA (200 nM) or CK2a siRNA at different concentra-
tions (200–20 nM) for 24 h prior to infection. Samples at 24 h
post-transfection were taken to confirm the successful knock-
down of CK2a protein levels prior to infection. Cells were then
infectedwithBTV1 atMOI 1 andharvested 14 h post-infection.
Lysates were then analyzed by Western blotting using specific
antibodies for each protein (Fig. 2A). Quantification ofWestern
blotting via densitometry confirmed that, at the time of infec-
tion (24 hpost-transfection), CK2a protein levels had decreased
by 65% ( 20%). Subsequent to infection, we observed a
concentration-dependent decrease in NS2 protein levels that
correlated to the corresponding decreases in CK2a protein lev-
els. The level CK2a protein at 14 h.p.i. was decreased by90%
( 5%) in the presence of 200 nM siRNA. This decrease corre-
lated with a62% decrease ( 6%) in NS2 protein levels. Sim-
ilarly, 100 nM siRNA also decreased CK2a protein levels85%
( 10%). This decrease correlatedwith a32%decrease ( 6%)
in NS2 protein levels (Fig. 2B). Furthermore, 200 and 100 nM
siRNA decreased the virus titer by 2 log10 and 1 log10,
respectively (Fig. 2C). To examine whether CK1 activity was as
important for BTV replication as CK2, we tested the effect of a
specific CK1 inhibitor, D4476 (22). CK1 inhibition did not
result in any significant decreases in viral protein levels at the
indicated concentrations (Fig. 3, A and B), nor did it have any
effect on virus titers (Fig. 3C) compared with the CK2 inhibitor
TBB, which served as a positive inhibition control. Cumula-
tively, these data confirm that CK2 but not CK1 activity is
important for BTV replication.
Identification of Protein Serine/Threonine PP2A as a novel
NS2 Interaction Partner Associatedwith theDephosphorylation
of NS2—It is likely that the phosphorylation state of NS2 is a
dynamic process and that it is co-regulated by a complementary
phosphatase that could function in concert with CK2, thereby
controlling NS2 phosphorylation dynamics. CK2 was previ-
ously found to directly interact with PP2A and act in concert
(23), making it a plausible candidate for our study. To explore
the potential role of PP2A, we tested a PP2A inhibitor, okadaic
acid (24), and an activator, FTY720 (25). HeLa cells were
infected with BTV1 atMOI 1 and, at 4 h.p.i., treated either with
a gradient of concentrations of okadaic acid (1–20 nM) or
FTY720 (2.5–20 M) for 20 h. As a replication inhibition con-
trol, 100 M TBB treatment was also included. Subsequent
Western blotting analysis showed that 5, 10, and 20MFTY720
interfered with viral replication, decreasing both NS2 and VP3
protein levels, similar to the effect of the control TBB treatment
that had been observed previously. Okadaic acid treatment did
not result in reduction of NS2 and VP3 protein levels (Fig. 4A).
When NS2 protein levels were normalized to -Actin levels via
densitometry in replicate experiments, FTY720 significantly
decreased replication compared with the untreated control
(Fig. 4B). At 20 M, FTY720 decreased NS2 protein levels by
almost70% ( 8%) and at 10 and 5 M by40% ( 7%) and
25% ( 7%), respectively, whereas 100 M TBB decreased
NS2 protein levels by over 50%.
To further support our observations, we examined the effects
of different concentrations of these drugs on virus growth. Cells
were infected and treated as above. Lysates were then used for
plaque assays. Consistent with theWestern blotting data, virus
titers in FTY720-treated cells also decreased, 2.5 log10 at 20
M, 2 log10 at 10 M, and 1 log10 at 5 M, respectively,
correlating with the decreased viral protein levels (Fig. 4C).
CK2 Inhibition or PP2A Activation Decreases NS2
Phosphorylation—To obtain direct evidence that CK2 or PP2A
affect NS2 phosphorylation, we quantified the phosphorylation
state of NS2 following CK2 and PP2A activity modulation.
HeLa cells were infected with BTV1 for 20 h before treatment
with either 100 M TBB, 10 M FTY720, or 20 nM okadaic acid
for 4 h. Cells were lysed, and NS2 was purified by immunopre-
cipitation. The presence of NS2 in the immunoprecipitation
fractions was verified usingWestern blotting (Fig. 5A). A dupli-
cate SDS-PAGE gel was stained sequentially with Pro-Q Dia-
mond phosphoprotein gel stain and SYPRO Ruby protein gel
stain to determine protein phosphorylation and total protein
concentrations, respectively (Fig. 5A). Fluorescence quantifica-
tion of the acquired images allowed for the generation of phos-
phoprotein to total protein ratios normalized toWT virus (Fig.
5B). For a negative control, we generated a NS2 phosphoryla-
tion mutant virus, where the previously identified phosphory-
lated serine sites (Ser-249 and Ser-259) were substituted by ala-
nine residues (SAA) using a reverse genetics system of BTV (16,
26).
The phosphoprotein-stained gel showedWTNS2phosphor-
ylated, but the SAAmutant lacking these phosphorylation sites
was not affected. This supports previous observations that Ser-
249 and Ser-259 are the principal sites of phosphorylation
within NS2. NS2 in the immunoprecipitation fractions from
WT, SAA, 100MTBB-treated, 10M FTY720-treated, and 20
nM okadaic acid-treated cells was quantified. Phosphoprotein
to total protein ratios showed that, when CK2 activity was
inhibited following TBB treatment, NS2 phosphorylation sig-
nificantly decreased by 30% ( 16%). Similarly, when PP2A
was activated using FTY720, NS2 phosphorylation significantly
decreased by30% ( 15%). However, when PP2A activity was
inhibited following okadaic acid treatment, no statistically sig-
nificant change could be observed (Fig. 5B).
CK2 and PP2A Co-regulate VIB Morphology—To further
investigate the effect of CK2 inhibition or PP2A activation on
VIB morphology, BTV-infected (WT or SAA) cells were tran-
siently treated with each pharmacological reagent. HeLa cells
were infected for 20hbefore treatmentwith either 100MTBB,
CK2 and PP2A Regulate BTV Assembly Sites
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10 M FTY720, or 20 nM okadaic acid for a further 4 h to min-
imize any potentialNS2protein turnover. Sampleswere probed
for NS2, VP7, VP5, and GAPDH (Fig. 6A).
Densitometry analysis ofWestern blots of each sample, both
for theWT and the SAAmutant viruses, showed no significant
decrease of NS2 protein levels following this transient drug
treatment (Fig. 6, A and B). However, the SAA mutant virus
displayed a replication deficiency, with NS2 protein levels
appreciably lower than those of the WT. Plaque assays showed
that, compared with the WT, the SAA mutant virus displayed
replication impairment with a titer of3 log10 lower than that
of theWT (Fig. 6C). Furthermore, the plaque morphology pro-
file differed, with the SAA mutant virus forming smaller
plaques compared with the WT at corresponding time points
post-infection (Fig. 6D).
Complementary immunofluorescence showed that VIBs of
WT virus were smaller and NS2 was more dispersed through-
out the cytoplasm when infected cells were treated with TBB
and FTY720 but larger when treated with Okadaic acid, follow-
ing this transient treatment. Concurrently, the SAA mutant
FIGURE 2. siRNA knockdown of CK2a inhibits BTV replication. HeLa cells were either mock-transfected (mock transf.) or transfected with 200 nM control
(cont.) siRNA or a gradient of CK2a siRNA at concentrations (200–20 nM) for 24 h. Transfected cells were then infected (inf.) with BTV1 (MOI 1) for 14 h. A,
samples were analyzed by Western blotting using specific antibodies as indicated. B, densitometry analysis of the Western blots are shown expressed as a
percentage representingNS2 (dotted columns) andCK2a (solid columns) protein levels relative toGAPDH.C, virus titer derived fromHeLa cells 14h.p.i. Error bars
represent the standard deviation values of stimulations from three independent experiments. *, p 0.05.
CK2 and PP2A Regulate BTV Assembly Sites
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virus produced smaller VIBs that appeared unresponsive to the
treatment (Fig. 6E). Quantification of immunofluorescence
images revealed that TBB treatment ofWT virus decreased the
mean size (square micrometers) of VIB by30% ( 9%). Sim-
ilarly, activation of PP2A via FTY720 resulted in a decrease of
mean VIB size by 30% ( 10%). When PP2A was inhibited
using okadaic acid, themean size of VIBs increased by13% (
2%). Although WT VIBs demonstrated these morphological
changes, VIBs of the SAAmutant virus VIBs showed no signif-
icant change in size under the same conditions. Furthermore,
the VIBs of the SAA mutant virus were significantly smaller
(40%  6%) compared with VIBs of WT virus (Fig. 6F).
Cumulatively, these data provide evidence for PP2A activity
influencing NS2 phosphorylation and, similar to CK2, affecting
VIBmorphology(formationandsize)andvirusreplication inde-
pendent of NS2 protein levels.
Discussion
BTV-induced VIBs, the site of viral replication and virus
assembly, are primarily composed of NS2 and are essential for
primary replication in vivo (17, 18). Although our previous
study had indicated the involvement of CK2 in themodification
of NS2 phosphorylation (16), the importance of CK2 activity in
BTV replication remained to be validated. Furthermore, a cor-
relating phosphatase and the dynamics that NS2 phosphoryla-
tion might orchestrate and control VIB assembly in vivo
remained unknown. Our studies here confirmed that CK2
activity is in fact important for BTV replication in vivo and that
PP2A co-regulates NS2 phosphorylation. However, in contrast,
CK1 inhibition did not impair BTV replication or influence
virus titer (Fig. 3, A–C) as opposed to CK2 inhibition. We have
confirmed that the inhibition of CK2 activity via a pharmaco-
logical inhibitor, TBB, during transient treatment affected NS2
dephosphorylation (Fig. 5) and mediated a decrease in VIB size
(Fig. 1, D and E). The size changes may be due to the VIB NS2
matrix disassembly because changes in the phosphorylation
state influence the capacity of NS2 to aggregate (16) and
thereby cause NS2:NS2 dissociation. Furthermore, prolonged
treatment resulted in inhibition of virus replication and
decreased virus titer in infected cells (Fig. 1, A–C). Similarly,
siRNA knockdown of CK2a inhibited BTV replication and
decreased virus titer (Fig. 2,A–C). These data also validate pre-
vious in vitro observations, in this case highlighting the impor-
tance of NS2 phosphorylation within the context of a produc-
tive viral replication cycle both for VIB formation as well as
production of infectious virus particles. Consistent with our
previous report (16), our data here show that CK2 influences
NS2 phosphorylation in vivo and supports a direct relationship
between NS2 phosphorylation, VIB formation, and size as well
as virus replication.
Expanding on the known phosphorylation dynamics of NS2,
we have also identified, for the first time, a phosphatase that
appeared to co-regulate phosphorylation of NS2 alongside
CK2. The PP2A holoenzyme is a heterotrimeric complex of a
scaffolding A subunit, a regulatory B-type subunit, and a
catalytic C subunit (27, 28). Although there are currently no
known consensus sequences in PP2A substrates (29), phar-
macological interventions specifically targeting PP2A
resulted in NS2 dephosphorylation and triggered NS2 phos-
phorylation-specific morphological changes in VIBs. Similar
observations were made in a sheep cell line, a natural host
species (data not shown).
Thus, several lines of evidence corroborate that PP2A con-
stitutes a component of the regulatory mechanism that modu-
lates NS2 phosphorylation dynamics alongside CK2. First, NS2
phosphorylation levels decreased during the activation of PP2A
following FTY720 treatment to similar levels observed when
CK2was inhibited using TBB. Second, VIBmorphology in cells
proved responsive to a pharmacological inhibitor and activator
that targets PP2A activity. Pharmacological inhibition of PP2A
using okadaic acid resulted in an increase in VIB size, whereas,
FIGURE 3. Inhibition of CK1 does not inhibit BTV replication. HeLa cells
infectedwithBTV1 (MOI1)were treated4h.p.i. with 100MTBBand10 and
20M of D4476 for 20 h. A, samples were analyzed byWestern blotting using
specific antibodies as indicated. B, densitometry analysis of theWestern blots
expressed as a percentage. C, virus titer derived fromHeLa cells infectedwith
BTV1 (MOI  1) and treated 4 h.p.i. with the indicated compound and con-
centration. Error bars represent the standard deviation values of stimulations
from three independent experiments. *, p 0.05.
CK2 and PP2A Regulate BTV Assembly Sites
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conversely, pharmacological activation of PP2A using FTY720
reduced VIB size.
Furthermore, by utilizing amutant virus lacking phosphor-
ylation sites (alanine substitutions at Ser-249 and Ser-259),
we showed that this virus displayed an impaired replication
profile compared with WT virus. Although we also docu-
mented that the phosphorylation state of Ser-249 and Ser-
259 could be modulated and that VIB morphology was
responsive to CK2 inhibition and PP2A inhibition and acti-
vation in WT virus, the SAA mutant remained unresponsive
to such modulation. This was clearly shown when pharma-
cological treatments did not elicit any significant changes in
VIB size.
However, it cannot be ruled out that other kinases or phos-
phatases are involved in the regulation of NS2 phosphorylation
and dephosphorylation. This was evidenced during prolonged
CK2 inhibition using TBB and siRNA knockdown of CK2a or,
similarly, prolonged activation of PP2A using FTY720. None of
these interventions could completely abolish BTV replication
or the production of infectious virus, although the decrease was
significant in each case. However, TBB, FTY720 and okadaic
acid were added post-entry (4 h.p.i.); thus, they could not
FIGURE 4. PP2A activity affects viral replication. HeLa cells infected with BTV1 (MOI 1) were treated 4 h.p.i. with TBB (a CK2 inhibitor), okadaic acid (an
inhibitor of PP2A), and FTY720 (an activator of PP2A) for 20 h at the indicated concentrations. A, samples were analyzed by Western blotting using specific
antibodies as indicated. B, densitometry analysis of the Western blots expressed as a percentage. C, virus titer derived from HeLa cells infected with BTV1
(MOI 1) and treated 4 h.p.i. with the indicated compound and concentration. Error bars represent the standard deviation values of stimulations from three
independent experiments. *, p 0.05.
CK2 and PP2A Regulate BTV Assembly Sites
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impair initial replication. Similarly, during the siRNA knock-
down experiment, some CK2a was still present. In each case,
thismayhave been sufficient for initial replication and infection
to be established. Overall, it should be noted that the SAA
mutant virus that lacked the NS2 phosphorylation sites while
virus growthwas significantly impaired still retained a low-level
capacity for replication, much like the WT virus treated with
CK2 inhibitor or PP2A activator.
Furthermore, the reduction of NS2 phosphorylation during
transient treatment of cells with the inhibitors and activator
achieved an 30% decrease in phosphorylation. This could
indicate the existence of otherNS2 phosphorylation regulators.
A further possible reason for this observation could be the tran-
sient nature of the treatment. Similarly, this could be a result of
enzyme kinetics or varying inhibitor efficiencies.
Within the context of the virus life cycle, this dynamic nature
ofNS2 phosphorylationmay facilitatemore thanVIB assembly.
Although the inner capsids (cores) of all members of the Reo-
viridae are assembled within inclusion bodies, the assembly of
the outer capsid and virion maturation take place outside of
these structures. Thus, the timely release of cores from VIBs is
an essential step in virion morphogenesis that must be regu-
lated. As cores traffick out of the virus inclusion bodies to
mature, the NS2 phosphorylation we have described could
plausibly serve as the key regulator. Functionally, phosphoryla-
tion of NS2 would modify the morphology of VIBs to allow
maturation to take place, with the balance of CK2 and PP2A
activities acting as the regulatory mechanism that facilitates
this, representing another case of host-virus interaction that
relates to virus infection and pathogenesis.
Experimental Procedures
Cell Lines and Virus—BSR cells (BHK-21 subclone, BHK21
cells (ATCC, CCL10TM) and HeLa cells (HeLa, ATCC, CCL-
2TM)) were maintained in DMEM (Sigma-Aldrich) supple-
mentedwith 10% (v/v) FBS (Invitrogen), 100 units of penicillin/
ml, and 100 g of streptomycin/ml (Sigma-Aldrich) and
minimum Eagle’s medium non-essential amino acids (Gibco).
FIGURE 5.NS2 phosphorylation at Ser-249 and Ser-259 decreases following CK2 inhibition or PP2A activation.HeLa cells infected with BTV1 (MOI 1)
were treated 20 h.p.i. for 4 h with 100 M TBB, 10 M FTY720, and 20 nM okadaic acid. NS2 was isolated from these cells using immunoprecipitation (IP). A,
samples were analyzed by Western blotting to confirm NS2 identity. SDS-PAGE gels were sequentially stained for phosphoproteins and total proteins. B,
densitometry analysis of phosphoprotein and total protein staining data in A from replicate experiments. NS2 is indicated along the detected Ig heavy chains
(HC). Error bars represent the standard deviation values of stimulations from three independent experiments. *, p 0.05.
CK2 and PP2A Regulate BTV Assembly Sites
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BTV serotype 1 (BTV1) stock was obtained by infecting BSR
cells at a low multiplicity of infection and harvested when a
100% cytopathic effect was evident. Virus stocks were stored at
4 °C. The BTV1 double alanine mutant (SAA) was generated
using the previously described reverse genetics system (18).
Pharmacological Reagents—The CK2 inhibitor TBB, the
PP2A activator FTY720, and the PP2A inhibitor okadaic acid
used were purchased from Santa Cruz Biotechnology, and the
CK1 inhibitor D4476 was purchased from Sigma-Aldrich. All
reagents were used at the concentrations specified.
Immunofluorescence Microscopy—HeLa cells were grown on
glass coverslips to 90% confluence prior to infection with BTV1
(MOI  1). At specified times, cells were washed with PBS
before being fixed for 10 min in 4% paraformaldehyde. Cells
were permeabilized with ice-cold methanol for 10 min. Cover-
slipswerewashedwith PBS and blockedwith 1%BSA in PBS for
1 h at room temperature. Coverslips were incubated with the
primary anti-NS2 antibody (guinea pig anti-NS2 serum) for 1 h
at room temperature andwashed in PBSbefore being incubated
with secondary antibody (goat anti-guinea pig IgG (HL) sec-
ondary antibody, Alexa Fluor 488 conjugate, A-11073, Thermo
Fisher) andHoechst 33342 (Invitrogen) for 1 h at room temper-
ature. Coverslips were washed with PBS before being mounted
on slides on mounting medium (Invitrogen).
Volocity High-performance Three-dimensional Imaging
Software—Lsm files were uploaded into Volocity software
(PerkinElmer Life Sciences). Data were analyzed using software
algorithms.
siRNAKnockdown—HeLa cells were transfected with 200 nM
Silencer negative control 1 siRNA (AM4611, Ambion) or with
SignalSilence CK2 siRNA I (6389, Cell Signaling Technolo-
gies) at different concentrations (200–20 nM) using Lipo-
fectamine RNAiMAX transfection reagent (13778-100, Invit-
rogen). Transfections were carried out according to the
instructions of the supplier. Cells were transfected for 24 h
prior to BTV1 (MOI 1) infection. Samples were harvested at
the indicated time points for Western blotting analysis.
Western Blotting Analysis—SDS-PAGE gels were transferred
via a semidry blotter to PVDF transfer membranes and blocked
for 4 h with Tris-buffered saline containing 0.05% Tween 20
and 10% (w/v) milk powder. The following primary antibodies
were used for the detection of: NS2 (guinea pig anti-NS2
serum), VP3 (rabbit anti-VP3 serum), -Actin (monoclonal
anti--Actin antibody produced in mouse, clone AC-74,
A2228, Sigma-Aldrich), GAPDH (rabbit anti-GAPDH (ab9485,
Abcam), anti-CKII  antibody (ab10466, Abcam). These were
added to blocked membranes and incubated overnight at 4 °C.
Secondary antibodies were an alkaline phosphatase-conjugated
goat anti-guinea pig IgG (1:10,000, Sigma-Aldrich, A5062),
goat anti-rabbit (A0418), and an alkaline phosphatase-conju-
gated goat anti-mouse (A3562) IgG (1:10,000, Sigma-Aldrich).
Immunoprecipitation—NS2 was purified from BTV1-in-
fected HeLa cells (MOI 1) after 24 h. Cells were washed with
PBS before lysis. Cells were lysed in lysis buffer (50 mM Tris-
HCl (pH 7.5), 125 mM NaCl, 5% Glycerol, 0.2% Nonidet P-40,
1.5 mMMgCl2, 25 mMNaF, 1 mMNa3VO4, and protease inhib-
itor) for 30 min on ice. Lysates were centrifuged at 5000 g for
10 min. Supernatants were recovered and added to protein
FIGURE 6. Transient treatmentwith CK2 inhibitor, PP2A inhibitor, or acti-
vatormodifyVIBmorphology in theWTvirusbutnot thealaninemutant
virus. HeLa cells infected with BTV1 (MOI  1) were treated 20 h.p.i. for 4 h
with 100 M TBB, 10 M FTY720, or 20 nM okadaic acid. A, samples were ana-
lyzed byWestern blotting using specific antibodies as indicated. B, densitom-
etry analysis of the Western blots expressed as a percentage. C, virus titer
derived from untreated HeLa cells infected with BTV1 WT and SAA mutant
virus (MOI 1). D, plaque assay plates of WT and SAAmutant virus at 48 and
72 h.p.i. E, HeLa cells infected with BTV1 WT and SAAmutant virus (MOI 1)
were treated 20 h.p.i. with 100 M TBB, 10 M FTY720, or 20 nM okadaic acid
for 4 h. F, VIBs denoted byNS2 staining ofWT (solid columns) and SAAmutant
(dotted columns) virus were quantified using Volocity software, and their size
was determined in replicate experiments of E. Error bars represent the stan-
dard deviation (Western blots) and standard error (confocal images) values of
stimulations from three independent experiments. *, p 0.05.
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A-Sepharose beads (Rabbit anti-NS2, conjugated) and were
incubated on ice overnight. Samples were centrifuged at
2000  g for 10 min. The supernatant was removed, and the
protein A-Sepharose beads washed with lysis buffer. Samples
were centrifuged at 2000 g for 10min. This wash process was
repeated four times. SDS loading buffer was then added to the
protein A-Sepharose beads before being boiled.
Phosphoprotein Staining—SDS-PAGE gels were sequentially
stained with Pro-Q Diamond phosphoprotein gel stain and
SYPRO Ruby protein gel stain (Thermo Fisher). For each stain,
the respective fluorescence was detected and quantified.
Author Contributions—B. P. M. and P. R. designed the study and
wrote the paper. B. P. M. designed, performed, and analyzed the
experiments.
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